Follow
Mika Naganawa
Mika Naganawa
Yale University School of Medicine, PET Center
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging
MK Chen, AP Mecca, M Naganawa, SJ Finnema, T Toyonaga, S Lin, ...
JAMA neurology 75 (10), 1215-1224, 2018
3542018
Lower synaptic density is associated with depression severity and network alterations
SE Holmes, D Scheinost, SJ Finnema, M Naganawa, MT Davis, ...
Nature communications 10 (1), 1529, 2019
3252019
PET kinetic analysis—compartmental model
H Watabe, Y Ikoma, Y Kimura, M Naganawa, M Shidahara
Annals of nuclear medicine 20, 583-588, 2006
2452006
In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
AP Mecca, MK Chen, RS O'Dell, M Naganawa, T Toyonaga, TA Godek, ...
Alzheimer's & Dementia 16 (7), 974-982, 2020
1852020
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C] SA4503
M Ishikawa, K Ishiwata, K Ishii, Y Kimura, M Sakata, M Naganawa, K Oda, ...
Biological psychiatry 62 (8), 878-883, 2007
1692007
Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis
M Naganawa, Y Kimura, K Ishii, K Oda, K Ishiwata, A Matani
IEEE transactions on biomedical engineering 52 (2), 201-210, 2005
1432005
Adenosine A2A Receptors Measured with [11C]TMSX PET in the Striata of Parkinson's Disease Patients
M Mishina, K Ishiwata, M Naganawa, Y Kimura, S Kitamura, M Suzuki, ...
PLoS One 6 (2), e17338, 2011
1392011
Synaptic changes in Parkinson disease assessed with in vivo imaging
D Matuskey, S Tinaz, KC Wilcox, M Naganawa, T Toyonaga, M Dias, ...
Annals of neurology 87 (3), 329-338, 2020
1262020
Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD
YS Ding, M Naganawa, JD Gallezot, N Nabulsi, SF Lin, J Ropchan, ...
Neuroimage 86, 164-171, 2014
952014
Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET
M Mishina, K Ishiwata, Y Kimura, M Naganawa, K Oda, S Kobayashi, ...
Synapse 61 (9), 778-784, 2007
902007
Assessment of a white matter reference region for 11C-UCB-J PET quantification
S Rossano, T Toyonaga, SJ Finnema, M Naganawa, Y Lu, N Nabulsi, ...
Journal of Cerebral Blood Flow & Metabolism 40 (9), 1890-1901, 2020
892020
Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology
RH Pietrzak, M Naganawa, Y Huang, S Corsi-Travali, MQ Zheng, ...
JAMA psychiatry 71 (11), 1262-1270, 2014
792014
Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
RS O’Dell, AP Mecca, MK Chen, M Naganawa, T Toyonaga, Y Lu, ...
Alzheimer's Research & Therapy 13, 1-12, 2021
652021
First-in-human evaluation of 18F-SynVesT-1, a radioligand for PET imaging of synaptic vesicle glycoprotein 2A
M Naganawa, S Li, N Nabulsi, S Henry, MQ Zheng, R Pracitto, Z Cai, ...
Journal of Nuclear Medicine 62 (4), 561-567, 2021
632021
In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib in a mouse model of Alzheimer disease
T Toyonaga, LM Smith, SJ Finnema, JD Gallezot, M Naganawa, J Bini, ...
Journal of Nuclear Medicine 60 (12), 1780-1786, 2019
632019
Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C] SA4503
M Sakata, Y Kimura, M Naganawa, K Oda, K Ishii, K Chihara, K Ishiwata
Neuroimage 35 (1), 1-8, 2007
632007
Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB‐J
AP Mecca, RS O'Dell, ES Sharp, ER Banks, HH Bartlett, W Zhao, S Lipior, ...
Alzheimer's & Dementia 18 (12), 2527-2536, 2022
602022
In vivo evidence of lower synaptic vesicle density in schizophrenia
R Radhakrishnan, PD Skosnik, M Ranganathan, M Naganawa, ...
Molecular Psychiatry 26 (12), 7690-7698, 2021
602021
Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study
MK Chen, AP Mecca, M Naganawa, JD Gallezot, T Toyonaga, J Mondal, ...
Journal of Cerebral Blood Flow & Metabolism 41 (9), 2395-2409, 2021
602021
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11C]UCB‐J positron emission tomography study
SJ Finnema, T Toyonaga, K Detyniecki, MK Chen, M Dias, Q Wang, ...
Epilepsia 61 (10), 2183-2193, 2020
572020
The system can't perform the operation now. Try again later.
Articles 1–20